Renal cell carcinoma: ESMO Clinical Recommendations for diagnosis, treatment and follow-up

被引：31

作者：

Escudier, B. ^{[1
]}

Kataja, V. ^{[2
,3
]}

机构：

[1] Inst Gustave Roussy, Villejuif, France

[2] Vaasa Cent Hosp, Vaasa, Finland

[3] Univ Kuopio, FIN-70211 Kuopio, Finland

来源：

ANNALS OF ONCOLOGY | 2009年 / 20卷

关键词：

INTERFERON-ALPHA; DOUBLE-BLIND; SUNITINIB; EFFICACY;

D O I：

10.1093/annonc/mdp137

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

页码：81 / 82

页数：2

共 13 条

[1] Choueiri TK, 2008, J CLIN ONCOL, V26, P127, DOI 10.1200/JCO.2007.13.3223
[2] Bevacizumab plus interferon alfa-2a for treatment of metastatic renal cell carcinoma: a randomised, double-blind phase III trial
Escudier, Bernard
Pluzanska, Anna
Koralewski, Piotr
Ravaud, Alain
Bracarda, Sergio
Szczylik, Cezary
Chevreau, Christine
Filipek, Marek
Melichar, Bohuslav
Bajetta, Emilio
Gorbunova, Vera
Bay, Jacques-Olivier
Bodrogi, Istvan
Jagiello-Gruszfeld, Agnieszka
Moore, Nicola
[J]. LANCET, 2007, 370 (9605) : 2103 - 2111
[3] Sorafenib in advanced clear-cell renal-cell carcinoma
Escudier, Bernard
Eisen, Tim
Stadler, Walter M.
Szczylik, Cezary
Oudard, Stephane
Siebels, Michael
Negrier, Sylvie
Chevreau, Christine
Solska, Ewa
Desai, Apurva A.
Rolland, Frederic
Demkow, Tomasz
Hutson, Thomas E.
Gore, Martin
Freeman, Scott
Schwartz, Brian
Shan, Minghua
Simantov, Ronit
Bukowski, Ronald M.
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (02) : 125 - 134
[4] PROGNOSTIC-SIGNIFICANCE OF MORPHOLOGIC PARAMETERS IN RENAL-CELL CARCINOMA
FUHRMAN, SA
LASKY, LC
LIMAS, C
[J]. AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1982, 6 (07) : 655 - 663
[5] RESULTS OF TREATMENT OF 255 PATIENTS WITH METASTATIC RENAL-CELL CARCINOMA WHO RECEIVED HIGH-DOSE RECOMBINANT INTERLEUKIN-2 THERAPY
FYFE, G
FISHER, RI
ROSENBERG, SA
SZNOL, M
PARKINSON, DR
LOUIE, AC
[J]. JOURNAL OF CLINICAL ONCOLOGY, 1995, 13 (03) : 688 - 696
[6] Epidemiologic and socioeconomic burden of metastatic renal cell carcinoma (mRCC): A literature review
Gupta, Kiran
Miller, Jeffrey D.
Li, Jim Z.
Russel, Mason W.
Charbonneau, Claudie
[J]. CANCER TREATMENT REVIEWS, 2008, 34 (03) : 193 - 205
[7] Temsirolimus, interferon alfa, or both for advanced renal-cell carcinoma
Hudes, Gary
Carducci, Michael
Tomczak, Piotr
Dutcher, Janice
Figlin, Robert
Kapoor, Anil
Staroslawska, Elzbieta
Sosman, Jeffrey
McDermott, David
Bodrogi, Istvan
Kovacevic, Zoran
Lesovoy, Vladimir
Schmidt-Wolf, Ingo G. H.
Barbarash, Olga
Gokmen, Erhan
O'Toole, Timothy
Lustgarten, Stephanie
Moore, Laurence
Motzer, Robert J.
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (22) : 2271 - 2281
[8] Prognostic factors for survival in previously treated patients with metastatic renal cell carcinoma
Motzer, RJ
Bacik, J
Schwartz, LH
Reuter, V
Russo, P
Marion, S
Mazumdar, M
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (03) : 454 - 463
[9] Efficacy of everolimus in advanced renal cell carcinoma:: a double-blind, randomised, placebo-controlled phase III trial
Motzer, Robert J.
Escudier, Bernard
Oudard, Stephane
Hutson, Thomas E.
Porta, Camillo
Bracarda, Sergio
Gruenwald, Viktor
Thompson, John A.
Figlin, Robert A.
Hollaender, Norbert
Urbanowitz, Gladys
Berg, William J.
Kay, Andrea
Lebwohl, David
Ravaud, Alain
[J]. LANCET, 2008, 372 (9637) : 449 - 456
[10] Sunitinib versus interferon alfa in metastatic renal-cell carcinoma
Motzer, Robert J.
Hutson, Thomas E.
Tomczak, Piotr
Michaelson, M. Dror
Bukowski, Ronald M.
Rixe, Olivier
Oudard, Stephane
Negrier, Sylvie
Szczylik, Cezary
Kim, Sindy T.
Chen, Isan
Bycott, Paul W.
Baum, Charles M.
Figlin, Robert A.
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (02) : 115 - 124

← 1 2 →